Omega Healthcare Investors, Inc.
NYSE:OHIREIT - Healthcare Facilities
-$0.86 today
- Market cap
- $14.33B
- Beta
- 0.58
- P/E (TTM)
- 21.0
- EPS (TTM)
- $2.13
- Dividend yield
- 6.00%
Volume 1.84M
Average 2.27M
OHI EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Omega Healthcare Investors, Inc.NYSE: OHI
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $514.24M rose 83.3% year over year, ahead of the +41.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 75.0% from the prior quarter. Over 3 fiscal years it compounded at +5.3% a year.
Context
- EBITDA amounted to 97.7% of revenue in FY2025, up 7.6 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $1.49B (+27.7%) for the fiscal year ending Dec 2026, a step up from the +23.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $514.24M+75.0% QoQ
- Last fiscal yearDec 2025
- $1.17B+23.5% YoY
- LTMJun 2026
- $1.45B+41.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +83.3% | -4.2% | -87.5 pp |
| 1 year | +23.5% | +27.7% | +4.1 pp |
| 3-year CAGR | +5.3% | +3.0% | -2.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 1.17B USD
- Year-over-year change
- +23.5%
- 4-year CAGR
- +4.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.17B | +23.5% |
| FY2024 | 2024-12-31 | 947.11M | +16.8% |
| FY2023 | 2023-12-31 | 810.84M | -19.1% |
| FY2022 | 2022-12-31 | 1B | +0.9% |
| FY2021 | 2021-12-31 | 992.7M | — |
EBITDA vs competitors
How OHI compares with its peers on the latest reported figures
- OHI's LTM Jun 2026 EBITDA of $1.45B is the 4th highest of the 11 companies compared; the peer median is $725.13M.
- Its year-over-year change of +41.6% is the 6th highest of 10, against a peer median of +45.6%.
- EBITDA amounts to 112.1% of revenue for OHI, versus a peer median of 62.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.33B | -5.4% | +4.2% | 24.3% | |
| LTM Jun 2026 | $2.48B | +27.0% | +14.3% | 38.5% | |
| LTM Sep 2026 | $1.76B | +15.8% | +1.1% | 78.5% | |
| LTM Jun 2026 | $1.45B | +41.6% | +5.3% | 112.1% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $1.05B | +979.1% | -31.2% | 103.2% |
| LTM Sep 2026 | $851.29M | +205.9% | +16.4% | 186.2% | |
| LTM Sep 2026 | $598.98M | +449.6% | +5.2% | 152.0% | |
| LTM Sep 2026 | $547.75M | +45.6% | +85.1% | 89.0% | |
| LTM Sep 2026 | $482.47M | +49.6% | +15.4% | 18.1% | |
| LTM Jun 2026 | $390.9M | -17.8% | +28.2% | 45.5% | |
| FY2025 | $211.75M | — | — | 27.5% | |
| Peer median (excluding OHI) | $725.13M | +45.6% | +14.3% | 62.0% | |
Competitors are the stored peer set for OHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.06B | 878.24M | 949.74M | 1.05B | 1.2B |
| Cost of Revenue | 12.26M | 15.5M | 15.03M | 14.56M | 664.93M |
| Gross Profit | 1.05B | 862.74M | 934.72M | 1.04B | 533.17M |
| Gross Margin | 98.8% | 98.2% | 98.4% | 98.6% | 44.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 64.63M | 69.4M | 81.5M | 88M | 0 |
| Operating Expenses | 484.38M | 470.47M | 445.74M | 377.17M | (216.27M) |
| Depreciation & Amortization | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M |
| EBITDA | 992.7M | 1B | 810.84M | 947.11M | 1.17B |
| EBITDA Margin | 93.4% | 114.1% | 85.4% | 90.1% | 97.7% |
| Operating Income | 566.17M | 392.28M | 488.97M | 659.66M | 749.44M |
| Operating Margin | 53.3% | 44.7% | 51.5% | 62.7% | 62.6% |
| Interest Income | 0 | 0 | 0 | 0 | 175.11M |
| Interest Expense | 234.6M | 233.24M | 235.53M | 221.72M | 220.54M |
| Other Income / Expenses | (134.03M) | 51.13M | (233.92M) | (231M) | (125.23M) |
| Income Before Tax | 432.14M | 443.4M | 255.05M | 428.66M | 624.22M |
| Pre-Tax Margin | 40.7% | 50.5% | 26.9% | 40.8% | 52.1% |
| Income Tax Expense | 3.84M | 4.56M | 6.26M | 10.86M | 14.75M |
| Net Income | 416.74M | 426.93M | 242.18M | 406.33M | 590.11M |
| Net Margin | 39.2% | 48.6% | 25.5% | 38.6% | 49.3% |
| EPS (Basic) | 1.76 | 1.81 | 1.01 | 1.57 | 2.02 |
| EPS (Diluted) | 1.75 | 1.80 | 1.00 | 1.55 | 1.94 |
| Weighted Avg Shares | 236.93M | 236.26M | 240.49M | 258.12M | 296.1M |
| Weighted Avg Shares (Diluted) | 244.34M | 244.29M | 250.45M | 270.45M | 310.7M |
Omega Healthcare Investors, Inc.
NYSE:OHI
Intrinsic Alpha fair value
Locked
Current Price
$47.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.